Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Şule Ketenci Ertaş
Antinuclear Antibodies Are Common and Linked to Poor Response to Omalizumab Treatment in Patients With CSU
Allergy: European Journal of Allergy and Clinical Immunology
Allergy
Immunology
Related publications
Omalizumab in Patients With Antihistamine-Resistant CSU
British Journal of Dermatology
Dermatology
Medicine
Are Currently Available Biomarkers Useful to Discriminate CSU Patients Not Controlled by Low Dose Omalizumab Maintenance Therapy?
European Annals of Allergy and Clinical Immunology
Allergy
Immunology
Antinuclear Antibodies in Patients With Raynaud's Phenomenon: Clinical Significance of Anticentromere Antibodies.
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Antinuclear Antibodies During Procainamide Treatment and Drug Acetylation.
BMJ
Positive Response to One-Year Treatment With Burosumab in Pediatric Patients With X-Linked Hypophosphatemia
Frontiers in Pediatrics
Child Health
Pediatrics
Perinatology
Therapeutic Switch From Omalizumab to Mepolizumab in Patients With Uncontrolled Severe Eosinophilic Asthma: Treatment Effect by Prior Omalizumab Treatment Duration
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Response to ‘Antinuclear Antibodies by Indirect Immunofluorescence and Solid Phase Assays’ by Bossuyt Et Al
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
THU0707 Analysis of Antinuclear Antibodies in Breast Cancer Patients
Omalizumab Treatment in Patients With Chronic Spontaneous Urticaria
Bőrgyógyászati és Venerológiai Szemle
